This study aims to evaluate the impact of prolonged prone ventilation on mortality rates in patients with severe acute respiratory distress syndrome (ARDS).
Multicenter trial of prolonged prone ventilation initiated early in patients with severe ARDS.
Patients were monitored for feasibility and safety of the intervention.
Prone ventilation is feasible and safe for clinical use in severe ARDS.
When applied early and for most of the day, it may significantly reduce mortality rates.
Abstract
Prone ventilation is feasible and safe, and may reduce mortality in patients with severe ARDS when it is initiated early and applied for most of the day.